Latest on the Affordable Care Act marketplaces: Will recent enrollment surge be short-lived?
In its final days, the Biden administration tried to cement gains made during the past few years in the uptake of insurance coverage provided through the Affordable Care Act (ACA) marketplaces. A final rule published Jan. 15 seeks to carry the recent momentum into 2026 via small steps and technical updates such as changes to…
How academic medical centers can foster greater alignment to advance strategic goals
The highly complex funds flow and diverse partnership structures of today’s academic medical centers (AMCs) make it difficult for leaders to align on important financial decisions. However, the evolution to value-based care and ongoing revenue challenges have inspired them to consider new approaches. As activity within AMCs continue to evolve, CFOs will play an important…
‘The responsibility is to work together’: HFMA’s Jordan, other healthcare leaders discuss how stakeholders are navigating turbulent times
With a new presidential administration bringing the potential for drastic changes and emotions about the industry running high, significant strain is on healthcare leaders. The best response is to search for opportunities to collaborate in the promotion of patient-centered policies, according to insights from a Jan. 24 conference hosted by the University of Miami’s Herbert…
Premier’s ERP solution addresses unique needs of the healthcare industry
How do you help healthcare organizations navigate the biggest challenges in healthcare? Premier provides a truly healthcare-native, enterprise resource planning (ERP) cloud-based SaaS solution, integrating supply chain, contract management, financial reporting and human resources (HR) capabilities end-to-end. Unlike traditional ERPs built to support multiple industries, Premier’s solution addresses healthcare’s unique needs as follows. When issues…
Where do we go now? Action needed to address public dissatisfaction with U.S. healthcare
Healthcare providers are examining their approaches to understanding and responding to mounting discontent, including addressing access, affordability and elimination of friction, as part of their responsibility to get healthcare right.
Robert F. Kennedy Jr. articulates his views on chronic disease, vaccines, Medicaid
Robert F. Kennedy Jr. will seek to chart a new course for U.S. healthcare if he becomes HHS secretary, he explained during a Jan. 29 confirmation hearing before the Senate Finance Committee. “President Trump has asked me to end the chronic disease epidemic and make America healthy again because I’m in a unique position to…
Medicaid funding questions swirl after White House orders widespread spending pause (updated)
Jan. 29 update: The White House on Wednesday retracted the OMB memo implementing the general pause of federal grant and loan spending, saying a stringent review of agency spending nonetheless will continue and funding for agencies and programs could still be frozen if deemed to be used in a way that’s contrary to the administration’s…
How healthcare leaders can automate workflows and improve financial performance
1. How do you help healthcare organizations navigate the biggest challenges in healthcare? Sage Intacct allows healthcare finance leaders to eliminate manual processes, automate workflows and improve financial performance across the organization. Sage enables multi-entity healthcare organizations to consolidate hundreds of entities in minutes. Not only does this simplify intercompany accounting, but it can also…
Proposed MA rate notice for 2026 looks promising for health plans, which soon could reap more gains
The Biden administration’s final action with respect to Medicare Advantage (MA) provided a boost to health plans, which could fare better yet under the Trump administration. For 2026, MA plans would receive a 2.23% increase in their payment benchmarks, according to an advance rate notice posted Jan. 10. That would represent a reversal from 2024…
Medicare Part D drug price negotiations are set to include GLP-1s, but questions abound
GLP-1 medications made the second round of drugs that are subject to price negotiations under the Inflation Reduction Act (IRA), according to a CMS announcement during the final days of the Biden administration. However, the future of Medicare’s price negotiation authority is uncertain following the transition of power in Washington, D.C. Congressional Republicans have criticized…